Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications

Journal of Clinical Oncology

Volumn 18, Issue 16, 2000, Pages 2981-2989

  Andre, Fabrice ^a   Grunenwald, Dominique ^a   Pignon, Jean Pierre ^a   Dujon, Antoine ^a   Pujol, Jean Louis ^a   Brichon, Pierre Yves ^a   Brouchet, Laurent ^a   Quoix, Elisabeth ^a   Westeel, Virginie ^a   Le Chevalier, Thierry ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING;

EID: 0033890742     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.16.2981     Document Type: Article

References (46)

1. Lymph node mapping and curability at Various levels of metastasis in resected lung cancer
2. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases
3. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung
4. Clinical prognostic factors in surgically treated stage IIIAN2 non small cell lung cancer: Analysis of the literature
5. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non small cell lung cancer
6. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non small cell lung cancer
7. Phase III trial of neo-adjuvant chemotherapy in resectable stage I (except T1N0), II IIIA non small-cell lung cancer (NSCLC): The French experience
8. PORT Meta-Analysis Trialists' Group: Post-operative radiotherapy in non-small cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomized controlled trials
9. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non small cell lung cancer: Mature results of a phase II trial
10. Concurrent cisplatin/ etoposide plus chest radiotherapy followed by surgery for stages IIIA(N2) and IIIB non small ceil lung cancer: Mature results of Southwest Oncology Group Phase II Study 8805
11. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer
12. Stage IIIA category of non-small cell lung cancer: A new proposal
13. Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice
14. Combined modalities therapy of non-small cell lung cancer
15. Anatomic basis of lymphatic spread from carcinoma of the luhg to the mediastinum: Surgical and prognostic implications
16. Mediastinal lymphatic spread of bronchopulmonary cancer
17. Revision in the international system for staging lung cancer
18. Clinical staging of primary lung cancer
19. Nonparametric estimation from incomplete observations
20. Regression models and life-tables
21. A randomized trial of induction chemotherapy plus high dose-radiation versus radiation alone in stage III non-small cell lung cancer
22. Radiotherapy alone versus combined chemotherapy and radiotherapy in non resectable non small cell lung cancer: First analysis of a randomized trial in 353 patients
23. Should subcarinal lymph nodes be routinely examined in patients with non small cell lung cancer?
24. Factors determining survival in resected N2 lung cancer
25. Aggressive surgical intervention in N2 non-small cell lung cancer
26. Prognostic significance of computed tomography in resected N2 lung cancer
27. Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases - The Leuven Lung Cancer Group
28. Mediastinal metastases in bronchogenic carcinoma: Influence of post-operative irradiation, cell type and location
29. Results of radical treatment of stage Ilia non-small cell carcinoma in the lung
30. Surgery for stage IIIA-N2 non-small cell lung cancer
31. The importance of surgery to non-small cell lung carcinoma with mediastinal lymph node metastasis
32. Results of resection for bronchogenic carcinoma with mediastinal lymph node metastasis in selected patients
33. Cancers bronchiques non aplasiques N2 operas: Evaluation multifactorielle du pronostic
34. Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease)
35. Pre-treatment evaluation of non-small cell lung cancer
36. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology
37. Mediastinoscopy, thoracoscopy, and video-assisted thoracic surgery in the diagnosis and staging of lung cancer
38. Surgical staging of lung cancer
39. Mediastinal lymph node detection with endosonography
40. Staging non small cell lung cancer by whole body positron emission tomographic imaging
41. Non small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling
42. Lymph node staging in non small cell lung cancer with FDG-PET Scan: A prospective study on 690 lymph node stations from 68 patients
43. N2 status at resection predicts long-term outcome following induction therapy for stage IIIA non-small cell lung cancer: CALGB 8935
44. Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial
45. Effects of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients, GETCB, FNCLCC and the CEBI trialists